Goldman Sachs cuts total voting rights in Evotec to 8.60% from 12.05%

EVO•2026-11-12

Goldman Sachs reduced its total voting rights in Evotec to 8.60% from 12.05%, effective Nov. 5, 2026.

1. Voting rights decline

Goldman Sachs’ voting rights through instruments fell to 8.28% from 11.69%, while voting rights attached to shares declined to 0.32% from 0.36%. The disclosure was published Nov. 12, 2026.

Goldman Sachs cuts total voting rights in Evotec to 8.60% from 12.05%

1. Voting rights decline

Related News

Takeda launches sleep disorder pill in the US after DEA clearance removes final hurdle

Northrop Grumman teams with Hermeus to field autonomous high-speed military aircraft

Occidental Petroleum publishes Q3 2026 earnings call transcript

Spyglass Pharma target price raised to $43 from $37 by H.C. Wainwright

US existing home sales slump to more than 16-year low in October